XERICO Antibody

What is XERICO and why is it significant in plant research?

XERICO is a small protein (162 amino acids) with an N-terminal transmembrane domain and a RING-H2 zinc-finger motif located at the C-terminus. It plays a crucial role in plant stress responses, particularly drought tolerance. The gene is induced by salt and osmotic stress, making it a key focus in agricultural research . The XERICO protein functions as an E3 ubiquitin ligase, which means it participates in protein degradation pathways by facilitating the addition of ubiquitin to target proteins. Studies have shown that overexpression of XERICO results in increased cellular ABA levels, which directly affects plant responses to drought and other environmental stressors. This connection to ABA signaling pathways makes XERICO particularly important for understanding how plants adapt to challenging environmental conditions.

What is a XERICO antibody and how does it differ from other research tools?

A XERICO antibody is an immunoglobulin raised against the XERICO protein or specific peptide sequences derived from it. Unlike genetic approaches such as PCR or RNA-seq that detect XERICO at the nucleic acid level, antibodies allow researchers to study the protein's expression, localization, interactions, and post-translational modifications directly. XERICO antibodies can be polyclonal (derived from multiple B cell lineages) or monoclonal (derived from a single B cell lineage), each with distinct advantages for research applications. Polyclonal antibodies offer broader epitope recognition but potentially lower specificity, while monoclonal antibodies provide higher specificity but may be less robust to changes in protein conformation or modifications.

What epitopes of XERICO are typically targeted for antibody production?

The most common epitopes targeted for XERICO antibody production include:

• The RING-H2 domain sequences, particularly around the zinc coordination sites (C96, C99, C114, H119, C122 in ZmXerico1)

• The N-terminal transmembrane region

• Unique peptide sequences that distinguish XERICO from other RING domain proteins

It's important to note that targeting the RING-H2 domain may result in cross-reactivity with other RING domain proteins, while antibodies against unique sequences may have higher specificity but potentially lower sensitivity. When designing epitopes for XERICO antibody production, researchers should consider the amino acid conservation across species if working with homologs like ZmXerico1 in maize or AtXerico in Arabidopsis.

How can XERICO antibodies be used to study drought stress responses in plants?

XERICO antibodies can be instrumental in studying drought stress responses through several methodological approaches:

Protein expression analysis: Western blotting can be used to quantify XERICO protein levels in response to drought stress. Studies have shown that XERICO is upregulated under drought conditions, correlating with increased ABA levels . A time-course analysis using XERICO antibodies can reveal the temporal dynamics of XERICO expression following drought exposure.

Immunolocalization: Immunohistochemistry or immunofluorescence with XERICO antibodies can determine the subcellular localization of XERICO during drought stress. This is particularly important as translocation between cellular compartments may indicate activation of stress response pathways.

Protein-protein interaction studies: Co-immunoprecipitation using XERICO antibodies can identify drought-specific interaction partners. Research has shown that XERICO interacts with E2 ubiquitin-conjugating enzymes like AtUBC8 and F-box proteins like AtTLP9 , which may change under drought conditions.

Chromatin association: ChIP assays using XERICO antibodies can determine if XERICO associates with chromatin during drought stress, potentially indicating a role in transcriptional regulation beyond its E3 ligase activity.

For valid results, it's critical to include appropriate controls, such as samples from XERICO knockout plants or competing peptide controls to validate antibody specificity.

What is the recommended protocol for immunoprecipitation using XERICO antibodies?

Recommended Immunoprecipitation Protocol for XERICO:

• Sample preparation:

  • Harvest 1-2g of plant tissue and grind in liquid nitrogen

  • Add 4mL of extraction buffer (50mM Tris-HCl pH 7.5, 150mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, protease inhibitor cocktail)

  • Sonicate briefly (3 × 10s pulses)

  • Centrifuge at 14,000×g for 15 minutes at 4°C

• Pre-clearing:

  • Incubate supernatant with 50μL Protein A/G beads for 1 hour at 4°C

  • Remove beads by centrifugation

• Immunoprecipitation:

  • Add 2-5μg of XERICO antibody to pre-cleared lysate

  • Incubate overnight at 4°C with gentle rotation

  • Add 50μL fresh Protein A/G beads and incubate for 2 hours at 4°C

  • Collect beads by centrifugation

• Washing:

  • Wash beads 4 times with wash buffer (extraction buffer with 0.1% Triton X-100)

  • Perform a final wash with PBS

• Elution:

  • Add 50μL of 2× SDS sample buffer

  • Heat at 95°C for 5 minutes

  • Analyze by SDS-PAGE and Western blotting

For XERICO specifically, include 10mM N-ethylmaleimide in all buffers to preserve ubiquitination status, as XERICO functions as an E3 ligase . Also consider using protein cross-linking reagents like DSP (dithiobis[succinimidylpropionate]) for capturing transient interactions with E2 conjugating enzymes.

How can Western blotting with XERICO antibodies be optimized for plant tissue samples?

Optimizing Western blotting for XERICO detection in plant tissues requires addressing several plant-specific challenges:

Extraction optimization:

• Use a PVPP (polyvinylpolypyrrolidone)-enhanced buffer (100mM Tris-HCl pH 8.0, 150mM NaCl, 2mM EDTA, 1% Triton X-100, 2% β-mercaptoethanol, 1% PVPP) to remove phenolic compounds and secondary metabolites that can interfere with antibody binding

• Include protease inhibitors and deubiquitinase inhibitors to preserve XERICO and its ubiquitinated targets

Membrane selection:

• PVDF membranes generally provide better results than nitrocellulose for XERICO detection

• Low protein binding capacity membranes (0.2μm) may improve detection of the small (approximately 18kDa) XERICO protein

Blocking optimization:

• 5% non-fat dry milk in TBST often produces lower background than BSA for plant samples

• Consider adding 0.05% Tween-20 to reduce background

Signal enhancement:

• Use enhanced chemiluminescence (ECL) substrates with high sensitivity

• Consider tyramide signal amplification for low abundance XERICO detection

Controls:

• Include recombinant XERICO protein as a positive control

• Use tissues from XERICO knockout/knockdown plants as negative controls

• For cross-species detection, validate with recombinant proteins from target species

Optimizing these parameters is essential as XERICO expression can vary significantly with growth conditions and stress levels, making consistent detection challenging without proper protocol optimization.

How can XERICO antibodies be used to investigate the ubiquitination pathway in plants?

XERICO antibodies are powerful tools for investigating plant ubiquitination pathways due to XERICO's function as a RING-H2 E3 ubiquitin ligase. Several advanced methodological approaches can be employed:

In vitro ubiquitination assays:

• Immunoprecipitate XERICO using validated antibodies

• Add E1, E2 enzymes (preferably AtUBC8, a known interactor ), and ubiquitin

• Detect ubiquitination activity through Western blotting

• Compare wild-type XERICO with mutated versions (e.g., V98Q/W126R or C96G/C99G/C114G/H119F/C122G mutations that inactivate E3 ligase activity)

Identification of ubiquitination targets:

• Perform tandem immunoprecipitation: first for ubiquitinated proteins, then with XERICO antibodies

• Analyze via mass spectrometry to identify specific targets

• Validate targets with reverse co-immunoprecipitation

Temporal dynamics of ubiquitination:

• Use XERICO antibodies in pulse-chase experiments with tagged ubiquitin

• Monitor changes in ubiquitination patterns during stress responses

• Correlate with ABA levels, as XERICO overexpression increases cellular ABA

Domain-specific functions:

• Generate antibodies against specific XERICO domains (N-terminal transmembrane vs. RING-H2)

• Determine which domains interact with E2 enzymes and substrates

• Map functional regions through domain-specific immunoprecipitation

These approaches have revealed that ZmXerico1 can ubiquitinate nearby substrates, demonstrating authentic E3 ligase activity in vitro . When applying these methods, researchers should include appropriate controls such as zinc-chelating agents to disrupt RING domain function or mutations in key residues (V98, W126) that are critical for E3-E2 interaction .

What approaches can be used to study XERICO protein-protein interactions using antibodies?

Several sophisticated approaches using XERICO antibodies can elucidate protein-protein interactions:

Proximity-dependent biotin identification (BioID):

• Generate a XERICO-BirA* fusion protein

• Use XERICO antibodies to confirm expression and proper localization

• After biotin treatment, purify biotinylated proteins and identify by mass spectrometry

• This approach can identify weak or transient interactions that traditional co-IP might miss

Co-immunoprecipitation with crosslinking:

• Treat plant samples with membrane-permeable crosslinkers

• Immunoprecipitate with XERICO antibodies

• Identify interacting partners by mass spectrometry

• This approach has successfully identified interactions between XERICO and E2 ubiquitin-conjugating enzymes (AtUBC8) and ASK1-interacting F-box proteins (AtTLP9)

Förster Resonance Energy Transfer (FRET) with antibody validation:

• Create fluorescent protein fusions with XERICO and potential interactors

• Use XERICO antibodies to confirm that fusion proteins maintain native interactions

• Measure FRET to quantify protein proximity in vivo

• Particularly useful for membrane-associated interactions given XERICO's transmembrane domain

Yeast two-hybrid with antibody validation:

• Screen for interactors using Y2H

• Validate interactions in planta using co-immunoprecipitation with XERICO antibodies

• This combined approach has confirmed XERICO's interaction with ubiquitination machinery components

When designing these experiments, researchers should consider XERICO's membrane localization and its role in the ABA signaling pathway to provide physiological context for the interactions discovered.

How can XERICO antibodies be utilized in chromatin immunoprecipitation (ChIP) studies?

While XERICO is primarily known as an E3 ubiquitin ligase with a transmembrane domain, recent evidence suggests potential nuclear localization under specific conditions, making ChIP studies relevant. Here's a methodological approach for using XERICO antibodies in ChIP:

Modified ChIP protocol for membrane-associated proteins:

• Crosslinking optimization:

  • Use dual crosslinking: first with protein-specific crosslinker DSP (2mM, 30min), followed by formaldehyde (1%, 10min)

  • This two-step approach better preserves interactions of membrane-associated proteins with chromatin

• Nuclear isolation and sonication:

  • Extract nuclei using detergent-free buffers to maintain membrane integrity

  • Sonicate cautiously (10 cycles, 30s on/30s off) to fragment chromatin while preserving protein-DNA interactions

• Immunoprecipitation:

  • Pre-clear chromatin with protein A/G beads

  • Incubate with XERICO antibody overnight at 4°C

  • Include controls: IgG negative control, histone H3 positive control

• Washing and elution:

  • Use low-detergent buffers for washing to preserve membrane protein interactions

  • Elute protein-DNA complexes with elution buffer (1% SDS, 0.1M NaHCO₃)

• Reverse crosslinking and DNA purification:

  • Reverse crosslinks at 65°C overnight

  • Purify DNA using standard methods

• Analysis:

  • Perform qPCR for candidate loci (e.g., ABA-responsive genes, drought-stress elements)

  • Alternatively, perform ChIP-seq for genome-wide analysis

When implementing this protocol, researchers should be aware that XERICO may interact with chromatin indirectly through other proteins rather than binding DNA directly. Therefore, sequential ChIP (Re-ChIP) with antibodies against known transcription factors involved in ABA signaling can help distinguish direct from indirect associations. Furthermore, comparing ChIP results from normal conditions versus drought stress can reveal stress-specific chromatin associations of XERICO.

How can cross-reactivity issues with XERICO antibodies be addressed?

Cross-reactivity is a common challenge with XERICO antibodies due to conserved RING-H2 domains across multiple plant proteins. Here are methodological approaches to address this issue:

Epitope selection strategies:

• Target unique regions outside the conserved RING-H2 domain

• Generate antibodies against species-specific variants of XERICO

• Use synthetic peptides corresponding to unique XERICO sequences for immunization

Validation techniques:

• Perform Western blots with recombinant XERICO alongside related RING proteins

• Test antibodies on tissues from XERICO knockout/knockdown plants

• Conduct peptide competition assays with the immunizing peptide

Purification methods:

• Affinity-purify antibodies using immobilized XERICO protein

• Perform negative selection against related RING proteins

• Use tandem purification with multiple XERICO epitopes

Cross-reactivity assessment matrix:

When addressing cross-reactivity in experimental design, include methodological controls such as parallel experiments with pre-immune serum and gradient concentrations of competing peptides. Additionally, confirming key findings with orthogonal methods not dependent on antibodies (such as mass spectrometry or RNA-level measurements) can provide further validation.

What are common challenges in detecting XERICO in different plant tissues and how can they be overcome?

Detecting XERICO across different plant tissues presents several challenges due to varying expression levels, tissue-specific modifications, and interfering compounds. Here are methodological solutions:

Challenge 1: Low abundance in certain tissues

• Solution: Use immunoprecipitation followed by Western blotting rather than direct Western blotting

• Protocol adjustment: Add a signal amplification step using HRP-conjugated polymers or tyramide signal amplification

• Validation: Include recombinant XERICO protein dilution series to establish detection limits

Challenge 2: Tissue-specific post-translational modifications

• Solution: Use multiple antibodies targeting different XERICO epitopes

• Protocol adjustment: Include phosphatase and deubiquitinase inhibitors in extraction buffers

• Validation: Compare migration patterns across tissues with predicted modifications

Challenge 3: Secondary metabolite interference

• Solution: Optimize extraction buffers for specific tissues

• Protocol adjustment: For phenolic-rich tissues (leaves, fruits), include PVPP (2%) and increased β-mercaptoethanol (5%)

• Validation: Spike recombinant XERICO into tissue extracts to assess recovery

Challenge 4: Membrane localization complicating extraction

• Solution: Use specialized membrane protein extraction protocols

• Protocol adjustment: Include 0.5% sodium deoxycholate and 0.1% SDS in extraction buffers

• Validation: Perform subcellular fractionation to confirm extraction efficiency

Tissue-specific optimization guidelines:

Research has shown that XERICO expression can vary significantly between tissues and developmental stages, with drought stress inducing expression in specific tissues . When comparing tissues, normalization to tissue-specific housekeeping proteins rather than global standards provides more accurate quantification.

How should researchers interpret contradictory results from different XERICO antibodies?

Contradictory results from different XERICO antibodies can arise from several methodological factors. Here's a systematic approach to interpretation and resolution:

Epitope-dependent differences:

• Antibodies targeting different domains (N-terminal transmembrane region vs. RING-H2 domain) may detect different XERICO populations

• The C-terminal RING-H2 domain may be masked in certain protein complexes

• Post-translational modifications may affect epitope accessibility

Resolution approach:

• Map the exact epitopes of each antibody

• Test antibodies on recombinant XERICO fragments

• Use multiple antibodies in parallel to build a complete picture

Isoform-specific detection:

• Plants may express multiple XERICO isoforms or homologs (e.g., ZmXerico1 and ZmXerico2 in maize)

• Different antibodies may have varying affinities for specific isoforms

Resolution approach:

• Perform RNA-seq to identify expressed isoforms in your tissue

• Test antibodies against recombinant versions of each isoform

• Use isoform-specific primers for RT-PCR validation alongside antibody detection

Technical variables affecting interpretation:

Data integration framework:

• Generate a hypothesis that explains the pattern of contradictions

• Design validation experiments using orthogonal methods

• Consider that contradictory results may reflect biological reality (different pools of XERICO with different functions)

• Perform sequential immunoprecipitation with different antibodies to identify distinct XERICO complexes

Research has shown that XERICO interacts with multiple proteins in the ubiquitination pathway , so different antibodies may preferentially detect XERICO in different protein complexes, leading to apparently contradictory results that actually reflect different functional pools of the protein.

How are XERICO antibodies being used in studying climate resilience in crops?

XERICO antibodies have become instrumental in studying climate resilience mechanisms in crops, particularly in relation to drought tolerance. Recent methodological advances include:

Translational research approaches:

• Comparative immunoprofiling of XERICO expression in drought-tolerant versus susceptible crop varieties

• Correlation of XERICO protein levels with physiological drought response parameters

• Development of high-throughput ELISA-based screening for XERICO expression in breeding programs

Field-to-laboratory studies:

• Collection of field samples under varying drought conditions for XERICO quantification

• Correlation of field performance with XERICO expression and modification patterns

• Validation of laboratory findings in agricultural settings

Research has demonstrated that overexpression of ZmXerico1 and ZmXerico2 (maize homologs of XERICO) improves drought tolerance in both monocot and dicot species . This cross-species functionality makes XERICO a valuable target for developing climate-resilient crops. Studies have shown that ectopic overexpression of these genes can improve water use efficiency through mechanisms related to ABA signaling .

Emerging crops applications:

• XERICO antibodies are being used to study protein expression in orphan crops adapted to drought conditions

• Comparative studies between model plants and crops help translate fundamental knowledge to agricultural applications

• Time-course studies during drought stress are revealing the dynamics of XERICO-mediated adaptation

A particularly promising direction is the use of XERICO antibodies to study post-translational modifications that may regulate XERICO activity under stress conditions. For example, specific antibodies against phosphorylated or ubiquitinated XERICO forms can reveal regulatory mechanisms that might be exploited for crop improvement.

What new technologies are enhancing the specificity and sensitivity of XERICO detection?

Recent technological advances have significantly improved XERICO detection methods:

Single-molecule detection technologies:

• Single-molecule pull-down (SiMPull) using XERICO antibodies can detect protein complexes at extremely low abundance

• Digital ELISA platforms can quantify XERICO at femtomolar concentrations

• These approaches are particularly valuable for tissues with naturally low XERICO expression

Spatial proteomics approaches:

• Imaging mass cytometry using metal-conjugated XERICO antibodies provides subcellular resolution

• Proximity ligation assays (PLA) can detect XERICO interactions with specific partners in situ

• These methods preserve spatial information lost in traditional biochemical approaches

Microfluidic immunoassays:

• Lab-on-a-chip platforms with integrated XERICO antibody arrays enable rapid, high-throughput analysis

• Nanoliter sample volumes make these suitable for analysis of microdissected tissues

• Automated systems allow standardized processing that improves reproducibility

NextGen sequencing integration:

• CITE-seq (Cellular Indexing of Transcriptomes and Epitopes by Sequencing) combines XERICO antibody detection with RNA-seq

• This provides simultaneous protein and transcript information from the same cells

• Particularly valuable for understanding transcriptional/translational regulation of XERICO

Computational advances:

• Machine learning algorithms can distinguish specific from non-specific XERICO antibody binding patterns

• Structural modeling guides epitope selection and antibody improvement

• Network analysis integrates XERICO detection data with other -omics datasets

These technological advances are addressing key limitations in traditional XERICO antibody applications. For example, distinguishing closely related RING-domain proteins has become possible through higher specificity detection methods, while detecting XERICO in tissue types with naturally low expression is now feasible with amplification-based approaches.

How might CRISPR/Cas9 technology complement antibody-based studies of XERICO?

CRISPR/Cas9 technology provides powerful complementary approaches to antibody-based XERICO research:

Epitope tagging for improved detection:

• CRISPR-mediated insertion of epitope tags (FLAG, HA, etc.) at the endogenous XERICO locus

• Enables detection with validated commercial tag antibodies when specific XERICO antibodies are limiting

• Preserves endogenous regulation while improving detection specificity

• Particularly valuable for studying XERICO in non-model plant species where antibodies are unavailable

Validation of antibody specificity:

• Generation of XERICO knockout lines as negative controls for antibody validation

• Creation of domain-specific deletions to map epitopes of existing antibodies

• Introduction of species-specific XERICO variants to test antibody cross-reactivity

Functional studies complementing antibody approaches:

• CRISPR-mediated mutagenesis of key XERICO residues (e.g., zinc coordination sites C96, C99, C114, H119, C122)

• Creation of mutations mimicking post-translational modifications detected by specific antibodies

• Parallel analysis of mutant phenotypes and protein detection to correlate structure with function

Combined methodological workflows:

Research has shown that ZmXerico1 functions as an E3 ubiquitin ligase, with specific amino acid mutations (V98Q/W126R) completely inactivating this function . CRISPR-mediated introduction of these mutations in crop plants, followed by antibody-based detection of protein interactions, could reveal how E3 ligase activity contributes to drought tolerance while maintaining endogenous expression patterns.

A particularly promising direction is CRISPR-based chromatin imaging combined with XERICO antibody detection to study the potential nuclear roles of XERICO in regulating gene expression during stress responses.